Gen2 Neuroscience Company

Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.

Funding Status: Seed
Industry: NeuroTech
Headquarters: Manchester, Manchester, United Kingdom
Last Funding Date: 06-03-2016
Last Funding Type: Seed
Employee Number: 1-10
Investors Number: 1
Founded Date: 2016